ARTICLE | Clinical News

Allervax Cat allergy therapeutic data

March 14, 1994 8:00 AM UTC

IMUL (Waltham, Mass.) presented results from 91 allergic people treated with different doses of subcutaneous antigen, and challenged by exposure of up to 60 minutes to the cat allergen Fel dl in a controlled environment.

Doses tested were 7.5, 75, and 750 ug of the antigen peptide, given weekly for four weeks. At the American Academy of Allergy and Immunology meeting in Anaheim, Calif., the company said the two higher doses tested gave a statistically significant decrease in the ratings of 10 allergic symptoms at six weeks (p < 0.05). T cell changes were not statistically significant, the company said. ...